PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors

被引:248
作者
DeKoter, RP
Walsh, JC
Singh, H
机构
[1] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Pharmacol & Physiol Sci, Chicago, IL 60637 USA
[3] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA
关键词
granulocytes; hematopoiesis; macrophages; PU.1; transcription;
D O I
10.1093/emboj/17.15.4456
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PU.1 is a unique regulatory protein required for the generation of both the innate and the adaptive immune system. It functions exclusively in a cell-intrinsic manner to control the development of granulocytes, macrophages, and B and T lymphocytes. We demonstrate that mutation of the PU.1 gene causes a severe reduction in myeloid (granulocyte/macrophage) progenitors, PU.1 -/- myeloid progenitors can proliferate in vitro in response to the multilineage cytokines interleukin-3 (IL-3), IL-6 and stem cell factor but are unresponsive to the myeloid-specific cytokines granulocyte-macrophage colony-stimulating factor (GM-CSF), G-CSF and M-CSF, The failure of PU.1 -/- progenitors to respond to G-CSF is bypassed by transient signaling with IL-3, In the presence of IL-3 and G-CSF, PU.1 -/- progenitors can differentiate into granulocytic precursors containing myeloperoxidase-positive granules. Thus PU.1 is not essential for specification of granulocytic precursors, but is required for their further differentiation. The failure of PU.1 -/- progenitors to respond to M-CSF is due to lack of c-fms gene transcription. Transduction of c-fms into PU.1 -/- myeloid progenitors bypasses the block to M-CSF-dependent proliferation but does not induce detectable macrophage differentiation. Therefore, PU.1 appears to be essential for specification of monocytic precursors. Importantly, retroviral transduction of PU.1 into mutant progenitors restores responsiveness to myeloid-specific cytokines and development of mature granulocytes and macrophages. Thus PU.1 controls myelopoiesis by regulating both proliferation and differentiation pathways.
引用
收藏
页码:4456 / 4468
页数:13
相关论文
共 68 条
  • [31] MIURA N, 1993, EXP HEMATOL, V21, P143
  • [32] SPI-1/PU.1 - AN ONCOGENE OF THE ETS FAMILY
    MOREAUGACHELIN, F
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3): : 149 - 163
  • [33] SPI-1 IS A PUTATIVE ONCOGENE IN VIRALLY INDUCED MURINE ERYTHROLEUKEMIAS
    MOREAUGACHELIN, F
    TAVITIAN, A
    TAMBOURIN, P
    [J]. NATURE, 1988, 331 (6153) : 277 - 280
  • [34] CELL-SPECIFIC EXPRESSION OF THE MACROPHAGE SCAVENGER RECEPTOR GENE IS DEPENDENT ON PU.1 AND A COMPOSITE AP-1 ETS MOTIF
    MOULTON, KS
    SEMPLE, K
    WU, H
    GLASS, CK
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) : 4408 - 4418
  • [35] GRANULOCYTE-COLONY-STIMULATING FACTOR-RECEPTOR AND ITS RELATED RECEPTORS
    NAGATA, S
    FUKUNAGA, R
    [J]. GROWTH FACTORS, 1993, 8 (02) : 99 - 107
  • [36] Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions
    Nishinakamura, R
    Miyajima, A
    Mee, PJ
    Tybulewicz, VLJ
    Murray, R
    [J]. BLOOD, 1996, 88 (07) : 2458 - 2464
  • [37] MICE DEFICIENT FOR THE IL-3/GM-CSF/IL-5 BETA-C RECEPTOR EXHIBIT LUNG PATHOLOGY AND IMPAIRED IMMUNE-RESPONSE, WHILE BETA-IL3 RECEPTOR-DEFICIENT MICE ARE NORMAL
    NISHINAKAMURA, R
    NAKAYAMA, N
    HIRABAYASHI, Y
    INOUE, T
    AUD, D
    MCNEIL, T
    AZUMA, S
    YOSHIDA, S
    TOYODA, Y
    ARAI, K
    MIYAJIMA, A
    MURRAY, R
    [J]. IMMUNITY, 1995, 2 (03) : 211 - 222
  • [38] PEBP2/CBF, THE MURINE HOMOLOG OF THE HUMAN MYELOID AML1 AND PEBP2-BETA/CBF-BETA PROTO-ONCOPROTEINS, REGULATES THE MURINE MYELOPEROXIDASE AND NEUTROPHIL ELASTASE GENES IN IMMATURE MYELOID CELLS
    NUCHPRAYOON, I
    MEYERS, S
    SCOTT, LM
    SUZOW, J
    HIEBERT, S
    FRIEDMAN, AD
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) : 5558 - 5568
  • [39] PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation
    Olson, MC
    Scott, EW
    Hack, AA
    Su, GH
    Tenen, DG
    Singh, H
    Simon, MC
    [J]. IMMUNITY, 1995, 3 (06) : 703 - 714
  • [40] PAHL HL, 1993, J BIOL CHEM, V268, P5014